NDC 71335-0650 – Ondansetron

Ondansetron 4 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC71335-0650

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
Bryant Ranch Prepack
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA090469
Marketed since
April 12, 2010
Listing expires
December 31, 2026
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (10)

Package NDCDescriptionSince
71335-0650-090 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-0)Apr 3, 2024
71335-0650-130 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-1)Oct 4, 2018
71335-0650-220 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-2)Oct 23, 2018
71335-0650-310 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-3)Oct 3, 2018
71335-0650-46 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-4)Feb 12, 2019
71335-0650-560 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-5)Jan 10, 2019
71335-0650-69 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-6)May 24, 2019
71335-0650-75 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-7)Mar 28, 2018
71335-0650-815 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-8)Oct 29, 2018
71335-0650-93 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-9)Nov 5, 2020

Other Ondansetron products